Jefferies Raises Price Target for Camurus
Investment bank Jefferies has increased its price target for Camurus, citing expectations for accelerated growth of the product Brixadi in the coming year.
Stocks · News reference
Danske Bank has increased its price target for Camurus to 826 SEK from 810 SEK while maintaining a 'buy' recommendation.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Investment bank Jefferies has increased its price target for Camurus, citing expectations for accelerated growth of the product Brixadi in the coming year.
Camurus AB announced its participation in the upcoming Jefferies Global Healthcare Conference.
Camurus has initiated a Phase 2b clinical trial for its weight-loss drug candidate, CAM2056, by dosing the first patient.
Uber stock dips slightly as a reported $17 billion DoorDash-Instacart mega-merger intensifies delivery competition ahead of Uber's Nov. 4 earnings report.
Uber Eats expanded its grocery footprint across the Northeast by adding 375+ Wakefern supermarkets, including ShopRite and Fairway Market locations.
Uber cuts 3,300 jobs (10% of staff) to slash management layers and simplify operations, bringing total workforce under 30,000.